Author:
Neumann Joachim,Dhein Stefan,Kirchhefer Uwe,Hofmann Britt,Gergs Ulrich
Abstract
Hallucinogenic drugs are used because they have effects on the central nervous system. Their hallucinogenic effects probably occur via stimulation of serotonin receptors, namely, 5-HT2A-serotonin receptors in the brain. However, a close study reveals that they also act on the heart, possibly increasing the force of contraction and beating rate and may lead to arrhythmias. Here, we will review the inotropic and chronotropic actions of bufotenin, psilocin, psilocybin, lysergic acid diethylamide (LSD), ergotamine, ergometrine, N,N-dimethyltryptamine, and 5-methoxy-N,N-dimethyltryptamine in the human heart.
Subject
Pharmacology (medical),Pharmacology
Reference179 articles.
1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus;Almaula;Mol. Pharmacol.,1996
2. Pharmacological assay of cardiac H2-receptor blockade by amitriptyline and lysergic acid diethylamide;Angus;Circ. Res.,1980
3. The hallucinogenic world of tryptamines: an updated review;Araújo;Arch. Toxicol.,2015
4. Molecular cloning and pharmacological characterization of the Guinea pig 5-HT1E receptor;Bai;Eur. J. Pharmacol.,2004
5. Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine;Balsara;Psychopharmacol. Berl.,1986